Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Creativity depression: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Graham
m Ref: SSRI's can induce this effect
>Graham
m New reference format
Line 1: Line 1:
<onlyinclude>
<onlyinclude>
'''Creativity suppression''' is a decrease in both a person's motivation and capabilities when performing tasks that involve producing artistic output or novel problem-solving.<ref name="Flaherty2005">Flaherty, A. W. (2005). Frontotemporal and dopaminergic control of idea generation and creative drive. Journal of Comparative Neurology, 493(1), 147-153. https://dx.doi.org/10.1002%2Fcne.20768</ref> This effect may be particularly frustrating to deal with for artists of any sort as it will induce a temporary creative block.   
'''Creativity suppression''' is a decrease in both a person's motivation and capabilities when performing tasks that involve producing artistic output or novel problem-solving.<ref name="Flaherty2005">{{cite journal|last1=Flaherty|first1=Alice W.|title=Frontotemporal and dopaminergic control of idea generation and creative drive|journal=The Journal of Comparative Neurology|volume=493|issue=1|year=2005|pages=147–153|issn=0021-9967|doi=10.1002/cne.20768}}</ref> This effect may be particularly frustrating to deal with for artists of any sort as it will induce a temporary creative block.   


Although creative subjects paradoxically more often have a history of depression than the average, their creative work is not done during their depressions, but in rebound periods of increased energy between depressions.<ref name="Flaherty2005"/><ref>Jamison, K. R. (1989). Mood disorders and patterns of creativity in British writers and artists. Psychiatry, 52(2), 125-134. https://www.ncbi.nlm.nih.gov/pubmed/2734415/</ref>
Although creative subjects paradoxically more often have a history of depression than the average, their creative work is not done during their depressions, but in rebound periods of increased energy between depressions.<ref name="Flaherty2005"/><ref>Jamison, K. R. (1989). Mood disorders and patterns of creativity in British writers and artists. Psychiatry, 52(2), 125-134. https://www.ncbi.nlm.nih.gov/pubmed/2734415/</ref>


Creativity suppression is often accompanied by other coinciding effects such as [[depression]],<ref>von Hecker, U., & Meiser, T. (2005). Defocused attention in depressed mood: evidence from source monitoring. Emotion, 5(4), 456. https://doi.org/10.1037/1528-3542.5.4.456</ref> [[anxiety]], and [[emotion suppression]] in a manner which further decreases the person's creative abilities.<ref name="Flaherty2005"/> It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[antipsychotics|antipsychotics]].<ref name="Flaherty2005"/><ref>Moncrieff, J., Cohen, D., & Mason, J. P. (2009). The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatrica Scandinavica, 120(2), 102-111. https://doi.org/10.1111/j.1600-0447.2009.01356.x</ref><ref name="Szmulewicz2016">Szmulewicz, A., Samamé, C., Caravotta, P., Martino, D. J., Igoa, A., Hidalgo-Mazzei, D., ... & Strejilevich, S. A. (2016). Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications. International journal of bipolar disorders, 4(1), 6. https://dx.doi.org/10.1186%2Fs40345-016-0047-3</ref> However, it can also occur due to SSRI's<ref>Bolling, M. Y., & Kohlenberg, R. J. (2004). Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychotherapy and psychosomatics, 73(6), 380-385. https://doi.org/10.1159/000080392</ref> and during the [[withdrawal]] symptoms of any dopaminergic compound.<ref name="Szmulewicz2016"/></onlyinclude>
Creativity suppression is often accompanied by other coinciding effects such as [[depression]],<ref name="von HeckerMeiser2005">{{cite journal|last1=von Hecker|first1=Ulrich|last2=Meiser|first2=Thorsten|title=Defocused Attention in Depressed Mood: Evidence From Source Monitoring.|journal=Emotion|volume=5|issue=4|year=2005|pages=456–463|issn=1931-1516|doi=10.1037/1528-3542.5.4.456}}</ref> [[anxiety]], and [[emotion suppression]] in a manner which further decreases the person's creative abilities.<ref name="Flaherty2005"/> It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[antipsychotics|antipsychotics]].<ref name="Flaherty2005"/><ref name="MoncrieffCohen2009">{{cite journal|last1=Moncrieff|first1=J.|last2=Cohen|first2=D.|last3=Mason|first3=J. P.|title=The subjective experience of taking antipsychotic medication: a content analysis of Internet data|journal=Acta Psychiatrica Scandinavica|volume=120|issue=2|year=2009|pages=102–111|issn=0001690X|doi=10.1111/j.1600-0447.2009.01356.x}}</ref><ref name="SzmulewiczSamamé2016">{{cite journal|last1=Szmulewicz|first1=Alejandro|last2=Samamé|first2=Cecilia|last3=Caravotta|first3=Pablo|last4=Martino|first4=Diego J.|last5=Igoa|first5=Ana|last6=Hidalgo-Mazzei|first6=Diego|last7=Colom|first7=Francesc|last8=Strejilevich|first8=Sergio A.|title=Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications|journal=International Journal of Bipolar Disorders|volume=4|issue=1|year=2016|issn=2194-7511|doi=10.1186/s40345-016-0047-3}}</ref> However, it can also occur due to SSRI's<ref name="BollingKohlenberg2004">{{cite journal|last1=Bolling|first1=Madelon Y.|last2=Kohlenberg|first2=Robert J.|title=Reasons for Quitting Serotonin Reuptake Inhibitor Therapy: Paradoxical Psychological Side Effects and Patient Satisfaction|journal=Psychotherapy and Psychosomatics|volume=73|issue=6|year=2004|pages=380–385|issn=0033-3190|doi=10.1159/000080392}}</ref> and during the [[withdrawal]] symptoms of any dopaminergic compound.<ref name="SzmulewiczSamamé2016"/></onlyinclude>
===Psychoactive substances===
===Psychoactive substances===
Compounds within our [[psychoactive substance index]] which may cause this effect include:
Compounds within our [[psychoactive substance index]] which may cause this effect include:

Revision as of 00:37, 8 September 2018

Creativity suppression is a decrease in both a person's motivation and capabilities when performing tasks that involve producing artistic output or novel problem-solving.[1] This effect may be particularly frustrating to deal with for artists of any sort as it will induce a temporary creative block.

Although creative subjects paradoxically more often have a history of depression than the average, their creative work is not done during their depressions, but in rebound periods of increased energy between depressions.[1][2]

Creativity suppression is often accompanied by other coinciding effects such as depression,[3] anxiety, and emotion suppression in a manner which further decreases the person's creative abilities.[1] It is most commonly induced under the influence of moderate dosages of antipsychotics.[1][4][5] However, it can also occur due to SSRI's[6] and during the withdrawal symptoms of any dopaminergic compound.[5]

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

See also

References

  1. 1.0 1.1 1.2 1.3 Flaherty, Alice W. (2005). "Frontotemporal and dopaminergic control of idea generation and creative drive". The Journal of Comparative Neurology. 493 (1): 147–153. doi:10.1002/cne.20768. ISSN 0021-9967. 
  2. Jamison, K. R. (1989). Mood disorders and patterns of creativity in British writers and artists. Psychiatry, 52(2), 125-134. https://www.ncbi.nlm.nih.gov/pubmed/2734415/
  3. von Hecker, Ulrich; Meiser, Thorsten (2005). "Defocused Attention in Depressed Mood: Evidence From Source Monitoring". Emotion. 5 (4): 456–463. doi:10.1037/1528-3542.5.4.456. ISSN 1931-1516. 
  4. Moncrieff, J.; Cohen, D.; Mason, J. P. (2009). "The subjective experience of taking antipsychotic medication: a content analysis of Internet data". Acta Psychiatrica Scandinavica. 120 (2): 102–111. doi:10.1111/j.1600-0447.2009.01356.x. ISSN 0001-690X. 
  5. 5.0 5.1 Szmulewicz, Alejandro; Samamé, Cecilia; Caravotta, Pablo; Martino, Diego J.; Igoa, Ana; Hidalgo-Mazzei, Diego; Colom, Francesc; Strejilevich, Sergio A. (2016). "Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications". International Journal of Bipolar Disorders. 4 (1). doi:10.1186/s40345-016-0047-3. ISSN 2194-7511. 
  6. Bolling, Madelon Y.; Kohlenberg, Robert J. (2004). "Reasons for Quitting Serotonin Reuptake Inhibitor Therapy: Paradoxical Psychological Side Effects and Patient Satisfaction". Psychotherapy and Psychosomatics. 73 (6): 380–385. doi:10.1159/000080392. ISSN 0033-3190.